Renaissance Technologies - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$76,370,000
+326.6%
352,100
+127.0%
0.10%
+400.0%
Q4 2020$17,900,000
+113.6%
155,103
+80.1%
0.02%
+137.5%
Q3 2020$8,382,000
-68.0%
86,102
-65.6%
0.01%
-60.0%
Q4 2019$26,158,000
-24.2%
250,171
-16.6%
0.02%
-31.0%
Q3 2019$34,509,000
+1118.1%
300,000
+1729.3%
0.03%
+866.7%
Q3 2018$2,833,000
-81.0%
16,400
-84.6%
0.00%
-62.5%
Q2 2018$14,903,000
+571.3%
106,800
+535.0%
0.01%
+300.0%
Q4 2017$2,220,000
-73.6%
16,820
-80.0%
0.00%
-81.8%
Q2 2017$8,421,000
-22.8%
84,000
-6.9%
0.01%
-26.7%
Q1 2017$10,909,000
-15.7%
90,200
-49.7%
0.02%
-40.0%
Q1 2016$12,944,000
+23.2%
179,400
+18.6%
0.02%
+8.7%
Q4 2015$10,506,000
+995.5%
151,300
+1341.0%
0.02%
+1050.0%
Q3 2015$959,000
+352.4%
10,500
+105.9%
0.00%
+100.0%
Q4 2013$212,0005,1000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2019
NameSharesValueWeighting ↓
Copernicus Capital Management, LLC 52,488$5,110,0004.87%
GREAT POINT PARTNERS LLC 520,232$50,645,0004.56%
Integral Health Asset Management, LLC 65,000$6,328,0001.94%
CLOUGH CAPITAL PARTNERS L P 190,716$18,566,0001.34%
Parkman Healthcare Partners LLC 50,000$4,868,0001.29%
ETF MANAGERS GROUP, LLC 375,344$36,540,0001.16%
Redwood Investments, LLC 124,094$12,081,0001.02%
Eventide Asset Management 436,000$42,445,0000.83%
Bellevue Group AG 562,943$54,803,0000.76%
ROOSEVELT INVESTMENT GROUP LLC 95,499$9,297,0000.75%
View complete list of GW PHARMACEUTICALS PLC shareholders